LXRX Lexicon Pharmaceuticals | $1.90 +5.8% | 9/28/2026 | | Initiated Coverage | $8.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 9/28/2026 |
PAYX Paychex | $99.30 -2.0% | 9/28/2026 | | Lower Price Target | $112.00 ➝ $96.00 | Underweight | 00.00% | View details for Cantor Fitzgerald rating of Paychex (NASDAQ:PAYX) on 9/28/2026 |
ASND Ascendis Pharma A/S | $230.05 +2.0% | 9/25/2026 | | Reiterated Rating | $300.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/25/2026 |
PRCH Porch Group | $16.83 +1.8% | 9/25/2026 | | Boost Price Target | $18.00 ➝ $20.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 9/25/2026 |
XYZ Block | $73.32 -4.1% | 9/25/2026 | | Reiterated Rating | $95.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Block (NYSE:XYZ) on 9/25/2026 |
ARCT Arcturus Therapeutics | $14.46 +4.4% | 9/24/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/24/2026 |
AJG Arthur J. Gallagher & Co. | $228.95 -0.9% | 9/24/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Arthur J. Gallagher & Co. (NYSE:AJG) on 9/24/2026 |
MESO Mesoblast | $14.50 -4.1% | 9/24/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 9/24/2026 |
ROIV Roivant Sciences | $36.98 +3.3% | 9/24/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Roivant Sciences (NASDAQ:ROIV) on 9/24/2026 |
DY Dycom Industries | $266.70 -1.8% | 9/24/2026 | | Reiterated Rating | $476.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Dycom Industries (NYSE:DY) on 9/24/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
CMPX Compass Therapeutics | $1.11 -1.8% | 9/23/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Compass Therapeutics (NASDAQ:CMPX) on 9/23/2026 |
ENHA Enhanced Group | $1.55 +7.3% | 9/23/2026 | | Initiated Coverage | $4.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Enhanced Group (NYSE:ENHA) on 9/23/2026 |
ESTC Elastic | $88.21 +0.1% | 9/23/2026 | | Reiterated Rating | $100.00 | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Elastic (NYSE:ESTC) on 9/23/2026 |
META Meta Platforms | $715.62 -4.8% | 9/23/2026 | | Boost Price Target | $680.00 ➝ $860.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 9/23/2026 |
IDYA IDEAYA Biosciences | $38.22 +4.2% | 9/22/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 9/22/2026 |
FORM FormFactor | $130.97 +1.0% | 9/22/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of FormFactor (NASDAQ:FORM) on 9/22/2026 |
CAMT Camtek | $142.61 -3.0% | 9/22/2026 | | Reiterated Rating | $175.00 | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Camtek (NASDAQ:CAMT) on 9/22/2026 |
AEIS Advanced Energy Industries | $277.84 -0.7% | 9/22/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Advanced Energy Industries (NASDAQ:AEIS) on 9/22/2026 |
AVPT AvePoint | $13.67 +5.2% | 9/22/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of AvePoint (NASDAQ:AVPT) on 9/22/2026 |
SMMT Summit Therapeutics | $15.48 -0.8% | 9/22/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Summit Therapeutics (NASDAQ:SMMT) on 9/22/2026 |
AVBP ArriVent BioPharma | $29.30 +3.0% | 9/22/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of ArriVent BioPharma (NASDAQ:AVBP) on 9/22/2026 |
ANAB AnaptysBio | $50.80 -0.4% | 9/22/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of AnaptysBio (NASDAQ:ANAB) on 9/22/2026 |
LPCN Lipocine | $2.09 -0.5% | 9/22/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Lipocine (NASDAQ:LPCN) on 9/22/2026 |
ENTX Entera Bio | $2.69 -1.8% | 9/22/2026 | | Initiated Coverage | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Entera Bio (NASDAQ:ENTX) on 9/22/2026 |
OMER Omeros | $19.43 -3.2% | 9/22/2026 | | Upgrade | $22.00 | Neutral ➝ Overweight | 00.00% | View details for Cantor Fitzgerald rating of Omeros (NASDAQ:OMER) on 9/22/2026 |
CLDX Celldex Therapeutics | $31.49 +1.3% | 9/22/2026 | | Boost Price Target | $61.00 ➝ $72.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 9/22/2026 |
PTCT PTC Therapeutics | $65.95 +5.2% | 9/22/2026 | | Boost Price Target | $130.00 ➝ $137.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 9/22/2026 |
ETOR eToro Group | $25.82 -2.2% | 9/21/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of eToro Group (NASDAQ:ETOR) on 9/21/2026 |
JOBY Joby Aviation | $6.11 -3.4% | 9/21/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 9/21/2026 |
SATL Satellogic | $6.05 -1.9% | 9/21/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Satellogic (NASDAQ:SATL) on 9/21/2026 |
LUNR Intuitive Machines | $15.20 -2.6% | 9/21/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 9/21/2026 |
AUR Aurora Innovation | $5.29 -12.4% | 9/21/2026 | | Reiterated Rating | $12.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Aurora Innovation (NASDAQ:AUR) on 9/21/2026 |
LCID Lucid Group | $3.90 -4.2% | 9/21/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 9/21/2026 |
RKLB Rocket Lab | $72.19 -2.4% | 9/21/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Rocket Lab (NASDAQ:RKLB) on 9/21/2026 |
SRRK Scholar Rock | $49.13 +1.0% | 9/21/2026 | | Reiterated Rating | $70.00 | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Scholar Rock (NASDAQ:SRRK) on 9/21/2026 |
FIVN Five9 | $34.66 -3.1% | 9/21/2026 | | Boost Price Target | $34.00 ➝ $40.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 9/21/2026 |
MSFT Microsoft | $509.22 -1.3% | 9/21/2026 | | Boost Price Target | $522.00 ➝ $608.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 9/21/2026 |
NOW ServiceNow | $131.27 -3.2% | 9/21/2026 | | Boost Price Target | $141.00 ➝ $174.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 9/21/2026 |
SECZ Securitize | $16.63 +4.2% | 9/21/2026 | | Initiated Coverage | $21.20 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Securitize (NYSE:SECZ) on 9/21/2026 |
TEAM Atlassian | $178.54 -4.9% | 9/21/2026 | | Boost Price Target | $175.00 ➝ $220.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 9/21/2026 |
MILLIONAIRE MASTERCLASS INVITE: Altucher (Ad) James Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th.
Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans.
Attendees who join early can also access a $1,000 bonus offer included with the presentation. Watch James Altucher's free masterclass before December 8th |
XRN Global Medical REIT | $35.52 -0.9% | 9/21/2026 | | Initiated Coverage | $43.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Global Medical REIT (NYSE:XRN) on 9/21/2026 |
EVMN Evommune | $8.38 -1.4% | 9/18/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Evommune (NYSE:EVMN) on 9/18/2026 |
ABEO Abeona Therapeutics | $5.29 -2.0% | 9/18/2026 | | Boost Price Target | $28.00 ➝ $30.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 9/18/2026 |
HUBS HubSpot | $203.50 -4.8% | 9/18/2026 | | Reiterated Rating | $200.00 | Neutral | 00.00% | View details for Cantor Fitzgerald rating of HubSpot (NYSE:HUBS) on 9/18/2026 |
RARE Ultragenyx Pharmaceutical | $14.41 -0.6% | 9/18/2026 | | Boost Price Target | $33.00 ➝ $39.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/18/2026 |
UPXI Upexi | $1.19 -3.3% | 9/18/2026 | | Reiterated Rating | $2.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Upexi (NASDAQ:UPXI) on 9/18/2026 |
ABOS Acumen Pharmaceuticals | $2.30 +2.7% | 9/17/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 9/17/2026 |
CRM Salesforce | $227.17 -2.9% | 9/17/2026 | | Reiterated Rating | $300.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Salesforce (NYSE:CRM) on 9/17/2026 |
ON onsemi | $75.65 -2.0% | 9/17/2026 | | Lower Price Target | $110.00 ➝ $90.00 | Neutral | 00.00% | View details for Cantor Fitzgerald rating of onsemi (NASDAQ:ON) on 9/17/2026 |
GNRC Generac | $205.03 -1.5% | 9/16/2026 | | Reiterated Rating | $333.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Generac (NYSE:GNRC) on 9/16/2026 |
ALMS Alumis | $7.16 +0.8% | 9/16/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Alumis (NASDAQ:ALMS) on 9/16/2026 |
CRVS Corvus Pharmaceuticals | $11.87 +2.2% | 9/16/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 9/16/2026 |
ABBV AbbVie | $266.39 +0.8% | 9/16/2026 | | Reiterated Rating | $250.00 ➝ $240.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of AbbVie (NYSE:ABBV) on 9/16/2026 |
AVTX Avalo Therapeutics | $15.08 -2.5% | 9/16/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Avalo Therapeutics (NASDAQ:AVTX) on 9/16/2026 |
MLTX MoonLake Immunotherapeutics | $11.56 -4.0% | 9/16/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 9/16/2026 |
QTTB Q32 Bio | $9.23 +5.2% | 9/16/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Q32 Bio (NASDAQ:QTTB) on 9/16/2026 |
ULTA Ulta Beauty | $549.13 +0.7% | 9/15/2026 | | Initiated Coverage | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Ulta Beauty (NASDAQ:ULTA) on 9/15/2026 |
MDXG MiMedx Group | $4.68 +0.2% | 9/15/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of MiMedx Group (NASDAQ:MDXG) on 9/15/2026 |
NYXH Nyxoah | $1.59 +9.7% | 9/15/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Nyxoah (NASDAQ:NYXH) on 9/15/2026 |
NPCE NeuroPace | $14.15 +0.6% | 9/15/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 9/15/2026 |
HOOD Robinhood Markets | $116.46 -2.5% | 9/15/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Robinhood Markets (NASDAQ:HOOD) on 9/15/2026 |
PCOR Procore Technologies | $49.14 -0.3% | 9/15/2026 | | Initiated Coverage | $65.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Procore Technologies (NYSE:PCOR) on 9/15/2026 |
BSY Bentley Systems | $31.29 -0.5% | 9/14/2026 | | Initiated Coverage | $37.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Bentley Systems (NASDAQ:BSY) on 9/14/2026 |
IOT Samsara | $37.97 +0.0% | 9/14/2026 | | Initiated Coverage | $45.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Samsara (NYSE:IOT) on 9/14/2026 |
ADSK Autodesk | $207.19 -1.1% | 9/14/2026 | | Initiated Coverage | $215.00 | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Autodesk (NASDAQ:ADSK) on 9/14/2026 |
PHVS Pharvaris | $31.91 -0.3% | 9/14/2026 | | Reiterated Rating | $65.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Pharvaris (NASDAQ:PHVS) on 9/14/2026 |
ASML ASML | $1,771.41 +1.6% | 9/14/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of ASML (NASDAQ:ASML) on 9/14/2026 |
ADSK Autodesk | $207.19 -1.1% | 9/14/2026 | | Upgrade | | Hold | 00.00% | View details for Cantor Fitzgerald rating of Autodesk (NASDAQ:ADSK) on 9/14/2026 |
BSY Bentley Systems | $31.29 -0.5% | 9/14/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Cantor Fitzgerald rating of Bentley Systems (NASDAQ:BSY) on 9/14/2026 |
FDMT 4D Molecular Therapeutics | $14.56 +0.6% | 9/14/2026 | | Upgrade | $20.00 | Neutral ➝ Overweight | 00.00% | View details for Cantor Fitzgerald rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 9/14/2026 |
IOT Samsara | $37.97 +0.0% | 9/14/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Cantor Fitzgerald rating of Samsara (NYSE:IOT) on 9/14/2026 |
PCOR Procore Technologies | $49.14 -0.3% | 9/14/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Cantor Fitzgerald rating of Procore Technologies (NYSE:PCOR) on 9/14/2026 |
META Meta Platforms | $715.62 -4.8% | 9/11/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 9/11/2026 |
CYTK Cytokinetics | $66.16 +2.3% | 9/11/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Cytokinetics (NASDAQ:CYTK) on 9/11/2026 |
INCY Incyte | $124.82 +0.8% | 9/11/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 9/11/2026 |
CVS CVS Health | $87.90 -1.4% | 9/11/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 9/11/2026 |
CNC Centene | $62.45 +1.0% | 9/11/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 9/11/2026 |
RCUS Arcus Biosciences | $25.03 +0.2% | 9/11/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Arcus Biosciences (NYSE:RCUS) on 9/11/2026 |
MNKD MannKind | $3.35 +0.3% | 9/11/2026 | | Reiterated Rating | $8.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 9/11/2026 |
ORCL Oracle | $132.64 -3.3% | 9/11/2026 | | Reiterated Rating | $229.00 ➝ $284.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 9/11/2026 |
DBVT DBV Technologies | $11.64 +0.7% | 9/10/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of DBV Technologies (NASDAQ:DBVT) on 9/10/2026 |
AQST Aquestive Therapeutics | $4.75 +1.5% | 9/10/2026 | | Reiterated Rating | $11.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Aquestive Therapeutics (NASDAQ:AQST) on 9/10/2026 |
BCAX Bicara Therapeutics | $18.80 -2.1% | 9/10/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Bicara Therapeutics (NASDAQ:BCAX) on 9/10/2026 |
TYRA Tyra Biosciences | $21.45 -1.4% | 9/10/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Tyra Biosciences (NASDAQ:TYRA) on 9/10/2026 |
TENX Tenax Therapeutics | $1.85 +2.2% | 9/10/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Tenax Therapeutics (NASDAQ:TENX) on 9/10/2026 |
SUIG Sui Group | $1.60 +0.6% | 9/10/2026 | | Boost Price Target | $1.70 ➝ $3.40 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Sui Group (NASDAQ:SUIG) on 9/10/2026 |
HYPD Hyperion DeFi | $3.91 -3.2% | 9/10/2026 | | Reiterated Rating | $7.10 ➝ $11.20 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Hyperion DeFi (NASDAQ:HYPD) on 9/10/2026 |
FWDI Forward Industries | $8.05 -4.4% | 9/10/2026 | | Boost Price Target | $8.00 ➝ $16.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Forward Industries (NASDAQ:FWDI) on 9/10/2026 |
DFDV DeFi Development | $5.57 -7.8% | 9/10/2026 | | Reiterated Rating | $4.70 ➝ $10.40 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of DeFi Development (NASDAQ:DFDV) on 9/10/2026 |
BMNR BitMine Immersion Technologies | $26.83 -2.7% | 9/10/2026 | | Boost Price Target | $30.60 ➝ $63.60 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of BitMine Immersion Technologies (NYSE:BMNR) on 9/10/2026 |
Should You Convert a Traditional IRA to a Roth After 60? (Ad) Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-free qualified withdrawals, and no lifetime required minimum distributions.
The catch: converting triggers ordinary income tax in the year you convert, and the decision cannot be reversed. The right move depends on your income, tax bracket, and retirement timeline. Take the free quiz to match with a vetted fiduciary advisor near you |
CSR Centerspace | $55.59 +0.5% | 9/10/2026 | | Reiterated Rating | $57.00 | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Centerspace (NYSE:CSR) on 9/10/2026 |
CYPH Cypherpunk Technologies | $3.31 -19.7% | 9/10/2026 | | Boost Price Target | $1.60 ➝ $4.90 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Cypherpunk Technologies (NASDAQ:CYPH) on 9/10/2026 |
PURR Hyperliquid Strategies | $12.08 -6.0% | 9/10/2026 | | Boost Price Target | $22.60 ➝ $34.20 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Hyperliquid Strategies (NASDAQ:PURR) on 9/10/2026 |
SBET Sharplink Gaming | $9.50 -1.3% | 9/10/2026 | | Boost Price Target | $8.30 ➝ $17.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Sharplink Gaming (NASDAQ:SBET) on 9/10/2026 |
UPXI Upexi | $1.19 -3.3% | 9/10/2026 | | Boost Price Target | $1.30 ➝ $2.00 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Upexi (NASDAQ:UPXI) on 9/10/2026 |
BRZE Braze | $23.17 -4.9% | 9/9/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Braze (NASDAQ:BRZE) on 9/9/2026 |
TXN Texas Instruments | $278.31 +0.1% | 9/9/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 9/9/2026 |
ON onsemi | $75.65 -2.0% | 9/9/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Cantor Fitzgerald rating of onsemi (NASDAQ:ON) on 9/9/2026 |
MCHP Microchip Technology | $77.97 -0.9% | 9/9/2026 | | Reiterated Rating | | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Microchip Technology (NASDAQ:MCHP) on 9/9/2026 |
SGMT Sagimet Biosciences | $9.94 +7.6% | 9/9/2026 | | Initiated Coverage | $10.71 | Overweight | 00.00% | View details for Cantor Fitzgerald rating of Sagimet Biosciences (NASDAQ:SGMT) on 9/9/2026 |